PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)

ANNÉE

2023

AUTEURS

M.P. Ducreux, R. Desgrippes, Y. Rinaldi, F. Di Fiore, R. guimbaud, L. Evesque, J. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. parzy, M. Bolliet, P.L. Etienne, J. Forestier, F. El Hajbi, A.L. Bignon Bretagne, V. Ly Lebrun, N. De Sousa Carvalho, M. Texier, O. Bouche

CONGRÈS/REVUE

ESMO

ÉTUDE

Localisation